The KRAS-G12C mutation, specifically, is identified in nearly one in seven patients. For decades KRAS was considered undruggable. As well as having very high affinity for its GTP/GDP substrates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback